N@N

Graig Suvannavejh Maintained (AXSM) at Strong Buy with Increased Target to $112 on, Feb 16th, 2024

Graig Suvannavejh of Mizuho, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $90 to $112 on, Feb 16th, 2024.

Graig has made no other calls on AXSM in the last 4 months.

There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 0 agree with Graig's Rating of Hold.

These are the ratings of the 6 analyists that currently disagree with Graig

---

• Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024
• Leonid Timashev of "RBC Capital" Initiated at Buy and Held Target at $126 on, Thursday, January 25th, 2024
• Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $108 on, Monday, January 22nd, 2024
• David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024
• Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Tuesday, December 26th, 2023
• David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $125 on, Wednesday, December 13th, 2023

Contributing Sources

---